Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
[Spasticity: from pathophysiology to treatment].
D A Iskra1, A P Kovalenko1, M A Koshkarev1
1Military Medical Academy n.a. S.M. Kirov, Saint-Petersburg, Russia.
This review details the pathophysiology of spasticity following upper motor neuron damage. It highlights neuroplasticity, pathogenesis, and current treatments like botulinum neurotoxin type A (BoNT) for rehabilitation.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Neuroscience
Background:
- Spasticity is a common, disabling outcome of upper motor neuron (UMN) damage.
- Understanding the pathophysiology of spasticity is crucial for effective management.
- Existing definitions and clinical presentations of spasticity require comprehensive analysis.
Purpose of the Study:
- To present modern perspectives on spasticity pathophysiology.
- To analyze the morphological and functional changes post-UMN damage.
- To review current diagnostic techniques and treatment strategies for spasticity.
Main Methods:
- Review of existing literature on spasticity pathophysiology and treatment.
- Analysis of neuroplasticity, pathogenesis, and sanogenesis in spasticity development.
- Comparison of pathogenetic mechanisms with clinical symptoms and diagnostic methods.
Main Results:
- Spasticity involves complex pathobiological processes in muscles, tendons, and joints.
- Botulinum neurotoxin type A (BoNT) and muscle relaxants are key treatments.
- BoNT is an integral component of comprehensive spasticity rehabilitation programs.
Conclusions:
- Effective spasticity management requires understanding its pathophysiological basis.
- Integrated treatment approaches, including BoNT, are essential for rehabilitation.
- Further research into diagnostic and therapeutic advancements is warranted.
Related Concept Videos
Pneumonia II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension II: Pathophysiology
Pathophysiology of Vomiting
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Heart Failure II: Pathophysiology

